Hosted on MSN9mon
Researchers find B cells drive responses of other immune cells, can be modified to prevent multiple sclerosis symptomsMore information: Rui Li et al, Oxidative phosphorylation regulates B cell effector cytokines and promotes inflammation in multiple sclerosis, Science Immunology (2024). DOI: 10.1126/sciimmunol ...
Researchers suggest the persistent inflammation from obesity may enhance the detrimental effects of intermittent or sustained ...
Researchers have made more advancements in multiple sclerosis in the last five years than in the previous 70 years. Knowing ...
Multiple sclerosis (MS) is one of the most widespread disabling neurological conditions of young adults around the world. It affects almost 1 million people in the United States, and about 2.9 ...
A Phase 2 clinical trial testing obexelimab in adults with relapsing types of multiple sclerosis is now recruiting ...
Our division, working in conjunction with the UAB Multiple Sclerosis Center, fosters clinical, research and educational activities in the area of neuroimmunology with emphasis on multiple sclerosis.
The first clinical consensus statement for managing multiple sclerosis (MS) in Australia and New Zealand has been released, ...
Immunic (IMUX – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Faisal Khurshid from ...
More information: Peripartum Mental Illness in Mothers With Multiple Sclerosis and Other Chronic Diseases in Ontario, Canada, Neurology (2025). DOI: 10.1212/WNL.0000000000210170 Journal ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback